Pharma: Das zweifelhafte Milliardengeschäft mit Frauen in den Wechseljahren
Aus dem Handelsblatt-Archiv: Investoren und Pharmafirmen stecken Milliarden in Produkte für Frauen in der Menopause. Dennoch fehlt es an wirksamen Therapien. Ein deutscher Anbieter profitiert.
Munich. For decades, investors and pharmaceutical companies paid scant attention to the complaints of women going through menopause – despite the fact that more than half of the world's population experiences this stage in their lives. Suddenly, hot flushes have become a hot business. Financial investors and private donors are pouring billions into the sale of products for women going through menopause.
Telemedicine providers hawk hormone therapies. Companies are offering programs for women in menopause as a new "employee benefit". The era when women silently endured their symptoms and kept the topic of menopause out of public view is over. Influencers and celebrities such as Oprah Winfrey and Serena Williams are promoting menopause products, with the hashtag #menopause racking up billions of views on TikTok.
The long-overdue momentum is here. However, few women are getting effective help. Does the investment boom address the actual problem?
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
